ATE226579T1 - Verbesserte verfahren fur assymmetrische hydrogenation - Google Patents

Verbesserte verfahren fur assymmetrische hydrogenation

Info

Publication number
ATE226579T1
ATE226579T1 AT00915771T AT00915771T ATE226579T1 AT E226579 T1 ATE226579 T1 AT E226579T1 AT 00915771 T AT00915771 T AT 00915771T AT 00915771 T AT00915771 T AT 00915771T AT E226579 T1 ATE226579 T1 AT E226579T1
Authority
AT
Austria
Prior art keywords
hydrogenation
assymmetric
improved methods
compound
formula
Prior art date
Application number
AT00915771T
Other languages
English (en)
Inventor
Bradley D Hewitt
Mark J Burk
Nicholas B Johnson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE226579T1 publication Critical patent/ATE226579T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Pyridine Compounds (AREA)
AT00915771T 1999-03-18 2000-03-14 Verbesserte verfahren fur assymmetrische hydrogenation ATE226579T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12505199P 1999-03-18 1999-03-18
PCT/US2000/003720 WO2000055150A1 (en) 1999-03-18 2000-03-14 Improved process for asymmetric hydrogenation

Publications (1)

Publication Number Publication Date
ATE226579T1 true ATE226579T1 (de) 2002-11-15

Family

ID=22417991

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00915771T ATE226579T1 (de) 1999-03-18 2000-03-14 Verbesserte verfahren fur assymmetrische hydrogenation

Country Status (11)

Country Link
US (1) US6211386B1 (de)
EP (1) EP1161427B1 (de)
JP (2) JP3610014B2 (de)
AT (1) ATE226579T1 (de)
AU (1) AU3699100A (de)
DE (1) DE60000660T2 (de)
DK (1) DK1161427T3 (de)
ES (1) ES2185582T3 (de)
PT (1) PT1161427E (de)
TW (1) TWI222970B (de)
WO (1) WO2000055150A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0026890D0 (en) * 2000-11-03 2000-12-20 Ici Plc Catalyst
AU2002344438B2 (en) * 2002-02-07 2008-09-11 Sumitomo Chemical Company, Limited Process for producing (R)-3-hydroxy-3-(2-phenylethyl)hexanoic acid and its intermediate
DE10313118A1 (de) 2003-03-24 2004-10-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Enantioselektive Hydrierung von Intermediaten bei der Tipranavir-Synthese

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171892A (en) 1991-07-02 1992-12-15 E. I. Du Pont De Nemours And Company Chiral phospholanes via chiral 1,4-diol cyclic sulfates
IL129871A (en) 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
ZA965853B (en) 1995-07-13 1998-01-12 Du Pont Merck Pharma Asymmetric synthesis of r and s warfarin and its analogs.
DK1015441T3 (da) * 1997-09-11 2004-07-26 Upjohn Co Fremgangsmåde til fremstilling af 4-hydroxy-2-oxo-pyranderivater, der er nyttige som proteaseinhibitorer

Also Published As

Publication number Publication date
EP1161427A1 (de) 2001-12-12
DK1161427T3 (da) 2003-02-24
JP2004307511A (ja) 2004-11-04
JP3610014B2 (ja) 2005-01-12
AU3699100A (en) 2000-10-04
WO2000055150A1 (en) 2000-09-21
ES2185582T3 (es) 2003-05-01
DE60000660D1 (de) 2002-11-28
JP4722413B2 (ja) 2011-07-13
DE60000660T2 (de) 2003-06-26
JP2002539205A (ja) 2002-11-19
US6211386B1 (en) 2001-04-03
EP1161427B1 (de) 2002-10-23
PT1161427E (pt) 2003-03-31
TWI222970B (en) 2004-11-01

Similar Documents

Publication Publication Date Title
Zhang et al. Gold (I)-catalyzed enantioselective hydroamination of N-allenyl carbamates
Pouy et al. Enantioselective, iridium-catalyzed monoallylation of ammonia
Keith et al. Asymmetric hydrocyanation of hydrazones catalyzed by lanthanide− PYBOX complexes
Ohmiya et al. Cu (I)-catalyzed intramolecular hydroamination of unactivated alkenes bearing a primary or secondary amino group in alcoholic solvents
Reznichenko et al. C 1-Symmetric rare-earth-metal aminodiolate complexes for intra-and intermolecular asymmetric hydroamination of alkenes
KR940013508A (ko) 우울증 및 파킨슨증후군 치료용 화합물
Li et al. Chiral C 2-symmetric ligands with 1, 4-dioxane backbone derived from tartrates: Syntheses and applications in asymmetric hydrogenation
ATE339430T1 (de) Katalysator für asymmetrische hydrogenierung
ATE522529T1 (de) Verfahren zur herstellung von pyridoä2,1- aüisochinolinderivaten, das die racematspaltung eines enamins umfasst
ES2171267T3 (es) Ferrocenildifosfinas funcionalizadas, un procedimiento para su preparacion y su uso.
DE60104825D1 (de) Verfahren zur herstellung von 6-substituierten (s)-nikotin-derivaten und zwischenverbindungen
BR0007610A (pt) Método para preparação de cloridrato del-fenilefrina
ATE554061T1 (de) Verfahren zur herstellung von aminen
DE69705035D1 (de) N-Azacycloalkylalkyldibenzothiophencarboxamide: spezifische Liganden für Dopaminrezeptorsubtypen
DE602004010830D1 (de) Verfahren zur herstellung von chiralen propionsäurederivaten
DE60000660D1 (de) Verbesserte verfahren fur assymmetrische hydrogenation
Etxebarria et al. (S, S)-(+)-pseudoephedrine as chiral auxiliary in asymmetric aza-michael reactions. unexpected selectivity change when manipulating the structure of the auxiliary
BRPI0409005A (pt) processo para a hidrogenação catalìtica de metilolalcanais
DE69912474D1 (de) Verfahren zur racematspaltung von tramadol
Stemmler et al. Planar-chiral cyrhetrenes for the Rhodium-catalyzed asymmetric 1, 4-addition and the hydrogenation of enamides
SG149776A1 (en) Organic metal compound and process for preparing optically-active alcohols using the same
Furness et al. Probes for Narcotic Receptor-Mediated Phenomena. 27. Synthesis and Pharmacological Evaluation of Selective δ-Opioid Receptor Agonists from 4-[(α R)-α-(2 S, 5 R)-4-Substituted-2, 5-dimethyl-1-piperazinyl-3-methoxybenzyl]-N, N-diethylbenzamides and Their Enantiomers
DE69920708D1 (de) Verfahren zur herstellung von 1,4-bis[[2-(dimethylamino)ethyl amino]-5,8-dihydroxyanthracene-9,10-dion
EP1510822A3 (de) Chemilumineszenzverfahren mittels eines 1,2-Dioxetanderivates, und dieses enthaltende Chemilumineszenz-Zusammensetzung
DE602006011360D1 (de) Katalysiertes verfahren zur herstellung von c-5-substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161427

Country of ref document: EP